Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 151 for Amyloidosis

Edit search filters
  1. A Study To Evaluate MEDI2228 In Subjects With Relapsed/ Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. The PRONTO Study, A Global Phase 2b Study Of NEOD001 In Previously Treated Subjects With Light Chain (AL) Amyloidosis

    Jacksonville, FL, Rochester, MN

  3. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

    Jacksonville, FL

  4. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant

    Jacksonville, FL

  5. Study Of The Safety And Efficacy Of STI-6129 In Patients With Relapsed Or Refractory Systemic AL Amyloidosis

    Jacksonville, FL, Rochester, MN

  6. TRITON-PN: A Study To Evaluate The Efficacy And Safety Of Nucresiran In Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

    Rochester, MN

  7. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant

    Rochester, MN

  8. MAGNITUDE: A Phase 3 Study Of NTLA-2001 In Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

    Rochester, MN

  9. A Study Of The Long-Term Safety Of Tafamidis For Patients With Transthyretin Cardiomyopathy

    Rochester, MN

  10. The Study Of An Investigational Drug, Patisiran (ALN-TTR02), For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis In Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran)

    Rochester, MN

.

Mayo Clinic Footer